All
Results: 29881-29892 of 81220

Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder

Leading the Future of AI Mobility: XPENG Showcases Its Latest Technology Breakthroughs at IAA Mobility 2025

Alkermes Presents Detailed Positive Results from Vibrance-1 Phase 2 Study of Alixorexton in Patients with Narcolepsy Type 1 at World Sleep Congress 2025








